KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Change in Inventory (2016 - 2025)

Elevance Health (ELV) has disclosed Change in Inventory for 17 consecutive years, with -$70.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 1500.0% to -$70.0 million in Q4 2025 year-over-year; TTM through Sep 2025 was $75.0 million, a 29.25% decrease, with the full-year FY2024 number at $78.0 million, down 1.27% from a year prior.
  • Change in Inventory was -$70.0 million for Q4 2025 at Elevance Health, down from $35.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $35.0 million in Q4 2022 to a low of -$70.0 million in Q4 2025.
  • A 5-year average of $10.8 million and a median of $16.5 million in 2023 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: skyrocketed 550.0% in 2024, then crashed 1500.0% in 2025.
  • Elevance Health's Change in Inventory stood at $14.0 million in 2021, then soared by 150.0% to $35.0 million in 2022, then decreased by 5.71% to $33.0 million in 2023, then plummeted by 84.85% to $5.0 million in 2024, then plummeted by 1500.0% to -$70.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Change in Inventory are -$70.0 million (Q4 2025), $35.0 million (Q3 2025), and $30.0 million (Q2 2025).